期刊文献+

新型阳离子聚合物非病毒载体介导野生型p53基因体外转染效果的研究

Study on effects of novel cationic polymer nonviral vector-mediated wild-type p53 gene transfection in vitro
下载PDF
导出
摘要 目的:研究新型阳离子聚合物非病毒载体———尿刊酸修饰的壳聚糖(UAC)介导野生型p53(wt-p53)基因体外转染人肝癌细胞系HepG2的效果。方法:载体UAC包裹含绿色荧光蛋白(GFP)报告基因和wt-p53治疗基因的质粒(pEGFP-p53)转染HepG2细胞,利用流式细胞术和荧光显微术检测细胞内GFP的表达,优选最佳转染条件;采用RT-PCR法检测细胞内p53mRNA的表达,流式细胞术评价基因转染对细胞周期的影响,Western blot法检测细胞内p53及其下游细胞周期调控蛋白的表达。结果:在低pH(pH=6.9)条件下,采用低壳聚糖分子量(20000)的UAC作为载体,与pEGFP-p53形成高N/P(N/P=30)的UAC/pEGFP-p53复合物转染HepG2细胞,可获得最佳转染效果;载体UAC介导wt-p53基因转染细胞后,p53mRNA表达水平明显上调,G0/G1期出现显著阻滞,p53、p21和Rb蛋白表达水平明显上调,cyclin D1和CDK4蛋白表达水平明显下调。结论:载体UAC可成功介导wt-p53基因转染HepG2细胞,并诱导其产生细胞周期阻滞。 AIM:To investigate the effects of novel cationic polymer nonviral vector urocanic acid-modified chitosan(UAC)-mediated wild-type p53(wt-p53) gene transfection in human hepatoma cell line HepG2 in vitro.METHODS: UAC packaged the plasmid pIRES2-EGFP-p53(pEGFP-p53) to form the UAC/pEGFP-p53 complexes which transfected HepG2 cells,and the pEGFP-p53 contained a report gene of green fluorescent protein(GFP) and a therapeutic gene of wt-p53.The GFP expression in cells was assayed by flow cytometry and fluorescence microscopy to screen the optimum transfection conditions.The expression of p53 mRNA in cells was analyzed by RT-PCR,cell cycle arrest was assessed by flow cytometry,and the expression of p53 and its downstream cell cycle regulatory proteins was assayed by Western blot.RESULTS:Under the conditions of the low pH(pH=6.9),high N/P(N/P=30),and low chitosan molecular weight(20000),the optimum transfection effect of UAC/pEGFP-p53 complexes in HepG2 cells could be obtained;UAC-mediated wt-p53 gene transfection in cells resulted in the significant G0/G1 phase arrest,the obvious upregulation of p53 mRNA and p53/p21/Rb protein expression levels,and the obvious downregulation of cyclin D1 and cyclin-dependent kinase(CDK) 4 protein expression levels.CONCLUSION: Wt-p53 gene could be successfully transfected into HepG2 cells mediated by UAC,which induced cell cycle arrest of HepG2 cells.
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第11期1227-1233,共7页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 江苏省自然科学基金资助项目(BK2011624) 江苏省高校长自然科学研究项目(10kjb310007) 中央高校基本科研业务费专项资金项目(JKQ2009017) 省级大学生实践创新训练计划项目
关键词 尿刊酸修饰的壳聚糖 野生型P53 基因转染 人肝癌细胞系 细胞周期阻滞 Urocanic acid-modified chitosan Wild-type p53 Gene transfection Human hepatoma cell line Cell cycle arrest
  • 相关文献

参考文献16

  • 1Al-Dosari MS, Gao X. Nonviral gene delivery: principle, limitations, and recent progress [J]. Aaps J, 2009, 11 (4): 671-681.
  • 2卢超,万江波,唐明清,肖卫东,许瑞安.重组腺相关病毒载体的免疫性研究及其解决策略[J].中国临床药理学与治疗学,2010,15(5):577-583. 被引量:1
  • 3Saranya N, Moorthi A, Saravanan S, et al. Chitosan and its derivatives for gene delivery[J]. Int J Biol Macromol, 2011, 48(2): 234--238.
  • 4Kim TH, Jiang HL, Nah JW, et al. Receptor-mediated gene delivery using chemically modified chitosan[J]. Biomed Mater, 2007, 2 (3): S95- 100.
  • 5李夷平,姚静,周建平,王伟.尿刊酸偶联壳聚糖基因载体的合成和表征[J].药学学报,2008,43(12):1233-1238. 被引量:7
  • 6Pirollo KF, Xu L, Chang EH. Non-viral gene delivery for p53 [J]. Curr Opin Mol Ther, 2000, 2 (2): 168--175.
  • 7Martinez JD. Restoring p53 tumor suppressor activity as an anticancer therapeutic strategy[J].Future Oncol, 2010, 6 (12): 1857--1862.
  • 8Sangro B, Qian C, Schmitz V, et al. Gene therapy of hepatoceilular carcinoma and gastrointestinal tumors [J]. Ann N Y Acad Sci, 2002, 963: 6-- 12.
  • 9Tong H, Qin S, Fernandes JC, et al. Progress and prospects of chitosan and its derivatives as non-vi ral gene vectors in gene therapy [J]. Curr Gene T her, 2009, 9 (6): 495--502.
  • 10Kim CK, Choi EJ, Choi SH, et al. Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC [J]. Gynecol On col, 2003, 90 (2): 265--272.

二级参考文献5

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部